MetaCap

Elevance Health Financial Ratios

NYSE: ELVHealth CareMedical SpecialitiesUSD

412.70+11.76 (+2.93%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Elevance Health ratio analysis

Elevance Health earned a net margin of 2.8% in FY 2025, down from 3.4% a year earlier. Gross margin was 89.4% compared with a median of 92.4% over the prior 8 years. Return on equity reached 12.9%, meaning Elevance Health generated 0.13 dollars of profit for every dollar of shareholders' equity.

Debt-to-equity stood at 0.73 versus 0.76 the year before, and the current ratio was 1.54. At the end of FY 2025, ELV traded at 14.1 times earnings; across the 10 fiscal years shown, its year-end P/E ranged from 14.1 to 21.1, with a median of 16.8. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.

Summary generated from market data by MetaCap's automated system. Methodology

Elevance Health financial ratios (annual)

Elevance Health annual financial ratios
RatioFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
P/E ratio (at fiscal year end)14.0514.4718.7021.1318.5817.8616.0717.6115.6815.61
Price / sales0.400.490.650.790.820.660.730.700.650.45
Price / book1.812.082.833.403.132.432.392.262.221.51
Gross margin89.4%88.8%89.9%91.7%92.1%92.7%98.1%100.0%100.0%—
Operating margin3.6%4.4%5.0%5.3%5.5%5.2%5.8%5.9%4.6%5.7%
Net margin2.8%3.4%3.5%3.8%4.4%3.8%4.6%4.1%4.3%2.9%
Free cash flow margin1.6%2.6%3.9%4.6%5.2%7.9%4.8%2.8%3.8%3.2%
Return on equity (ROE)12.9%14.5%15.2%16.3%17.1%13.8%15.2%13.1%14.5%9.8%
Return on assets (ROA)4.7%5.1%5.5%5.7%6.3%5.3%6.2%5.2%5.4%3.8%
Debt / equity0.730.760.640.670.640.600.630.670.750.63
Current ratio1.541.451.441.401.471.551.661.561.551.61
Revenue growth12.5%3.3%9.4%13.0%13.8%16.9%13.1%2.3%6.1%7.2%
EPS growth-1.8%1.8%3.9%-2.7%38.8%-2.7%30.2%-1.1%55.8%-1.8%

Related